Pharmacokinetic-guided Dosing of Emicizumab

Clinical trial NCT06320626 · RECRUITING

Trial details

NCT number: NCT06320626
Sponsor: Kathelijn Fischer
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Hemophilia A With Inhibitor Hemophilia A Without Inhibitor Hemophilia A, Severe Adolescent Child Adult

Start date: 2022-09-08
Primary completion: 2026-03-01
Enrollment: 95

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.